Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit - Schedule of Dilutive Effect of Common Shares (Details)

v3.10.0.1
Stockholders' Deficit - Schedule of Dilutive Effect of Common Shares (Details) - shares
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Common shares outstanding 7,365,881   39,502
Antidilutive securities 746,016,834 44,904  
Stock Options [Member]      
Antidilutive securities 77    
Warrants [Member]      
Antidilutive securities 463,449,767    
Convertible Debt [Member]      
Antidilutive securities 214,222,493    
Convertible Preferred Stock [Member]      
Antidilutive securities 68,344,495 142